As Vice-Chair, Dr. Susan E Cohn will work closely with Dr. Adriana Weinberg, Chair of A5376, and Dr. Kim Scarsi, co-Vice Chair, to oversee the overall conduct of this clinical trial. She will work closely with the entire study team to respond to the sites questions about the study, including procedures and/or patient eligibility concerns, and help to ensure that the protocol is enrolled and conducted in a timely fashion. She will review safety reports with the A5376 Core team and ensure the Team responds to site or ACTG leadership inquiries promptly, and participate on regular and ad hoc A5376 Team calls. After study completion, Dr. Cohn will work with the A5376 Team to review the final data report and work with the A5376 Writing team to write and finalize manuscripts describing study outcomes and safety, and help prepare presentations of the data at upcoming meetings.
|Effective start/end date||12/1/18 → 11/30/19|
- University of California at Los Angeles (1560GWB595//7UM1AI068363-13 REVISED)
- National Institute of Allergy and Infectious Diseases (1560GWB595//7UM1AI068363-13 REVISED)